ISDA

Deposition Date 2014-05-13

Release Date 2014-10-08

Last Version Date 2024-05-08

Entry Detail

PDB ID:

4D2W

Keywords:

TRANSFERASE

Title:

Structure of MELK in complex with inhibitors

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Host Organism:

ESCHERICHIA COLI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.92 Å

R-Value Free:

0.24

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE
Gene (Uniprot):MELK
Mutations:YES
Chain IDs:A, B, C, D
Chain Length:356
Number of Molecules:4
Biological Source:HOMO SAPIENS

UniProt ID:Q14680 Pfam ID:PF00069, PF21594

Ligand Molecules

NF5

Primary Citation

Fragment-Based Discovery of Type I Inhibitors of Maternal Embryonic Leucine Zipper Kinase

Johnson, C.N, Berdini, V, Beke, L, Bonnet, P, Brehmer, D, Coyle, J.E, Day, P.J, Frederickson, M, Freyne, E.J.E, Gilissen, R.A.H.J, Hamlett, C.C.F, Howard, S, Meerpoel, L, Mcmenamin, R, Patel, S, Rees, D.C, Sharff, A, Sommen, F, Wu, T, Linders, J.T.M.Show

Acs Med.Chem.Lett. 6 25 ? (2015)

PMID: 25589925 DOI: 10.1021/ML5001245

Abstact

Fragment-based drug design was successfully applied to maternal embryonic leucine zipper kinase (MELK). A low affinity (160 μM) fragment hit was identified, which bound to the hinge region with an atypical binding mode, and this was optimized using structure-based design into a low-nanomolar and cell-penetrant inhibitor, with a good selectivity profile, suitable for use as a chemical probe for elucidation of MELK biology.

Legend

Protein

Chemical

Disease

Primary Citation of related structures